Vimarsana
Biggest News Aggregation in the World

4503 To News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 4503 To. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 4503 To Today - Breaking & Trending Today

Dividend Investors Should Look Abroad. 3 Stocks From Europe and Japan. - Vimarsana News

Dividend Investors Should Look Abroad. 3 Stocks From Europe and Japan.

International equities yield more and cost less on average than U.S. stocks. Legrand, RELX, and Astellas Pharma are among the current prospects.

Merck, Pfizer, Astellas Get FDA OK For Expanded Use Of Keytruda Plus Padcev - Vimarsana News

Merck, Pfizer, Astellas Get FDA OK For Expanded Use Of Keytruda Plus Padcev

By Ben Glickman Merck & Co., Pfizer and Astellas Pharma have received approval from the U.S. Food and Drug Administration for using Keytruda in...

White House Plan to Cut Drug Prices Gets Shrugs From Investors - Vimarsana News

White House Plan to Cut Drug Prices Gets Shrugs From Investors

The Biden administration unveiled a plan to force drugmakers to license generic versions of patented drugs. Stocks barely budged.

Astellas, Seagen: Cancer Treatment Padcev Supplemental Biologics License Application Gets FDA Priority Review - Vimarsana News

Astellas, Seagen: Cancer Treatment Padcev Supplemental Biologics License Application Gets FDA Priority Review

By Stephen Nakrosis Astellas Pharma and Seagen said the Food and Drug Administration has accepted for priority review a supplemental biologics license...

Merck's Earnings Are Thursday. Here's What to Expect. - Vimarsana News

Merck's Earnings Are Thursday. Here's What to Expect.

Pharmaceutical stocks have generally fallen, partly because of regulatory concerns, but also because high interest rates have made the companies dividends...